Transcriptional Response to Tumor Mutational Burden Is Consistent Across Cancer Types

Shih, K. Y., Brandman, O., Winslow, M. M., Petrov, D. A.

10.64898/2026.08.27.744035 · was preprinted

biomedical

Surfaced because: matches the platform's topic region.

relevance 0.35 openness 0.00 novelty 0.34

Abstract

Tumor mutational burden (TMB) shapes tumor transcriptional state, but studies typically describe this response as an average effect pooled across cancer types. Whether that average reflects a consistent response present within individual cancer types, or is an artifact of merging heterogeneous, tissue-specific responses, remains unresolved. Here we analyze ~9,100 tumors across 32 TCGA cancer types to test whether the transcriptional response to TMB is genuinely consistent across tissues. We construct a TMB axis score from TMB-associated genes upregulated with increasing TMB, yielding a sample-level measure of response strength, and subsequently decompose it at the component and pathway/complex levels. The pooled transcriptional response to TMB stays largely consistent within each cancer type, and no single cancer is driving the pooled signal. This consistency was also observed at the component and pathway/complex levels. These findings support TMB as a promising tissue-agnostic signature, with implications for tissue-agnostic therapeutic targeting.

Lifecycle

biorxiv v1 2026-08-28 source ↗

Discussion

No qualifying discussion yet.